Architect HE4, Architect HE4 Calibrators and Architect HE4 Controls, Models 2, 2P54, 2P54-01, 2P54-10 SP54-01,
Test, Epithelial Ovarian Tumor Associated Antigen (He4). 510(k) K093957, from Fujirebio Diagnostics,Inc. (Malvern, PA). Product code OIU, class 2.
As of Nov 20, 2026, K093957 is an FDA 510(k) held by Fujirebio Diagnostics,Inc., substantially equivalent on Mar 18, 2010 after 85 days, with no recalls tied to it in FDA's recall database.
- Review time: 85 days
- Recalls: 0
- Cited as a predicate by: 2 devices
Reagent Kit The ARCHITECT HE4 assay is a chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of HE4 antigen in human serum. The assay is to be used as an aid in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer.
- HE4 Eia, Model: 404-10 USK072939 · Fujirebio Diagnostics,Inc. · Jun 9, 2008
- Elecsys HE4, Elecsys HE4 Calset, Elecsys Precicontrol HE4, Elecsys HE4 Calcheck 5K112624 · Roche Diagnostics · Sep 10, 2012
- Fujirebio Diagnostics Tumor Marker Control Model 108-20K101809 · Fujirebio Diagnostics,Inc. · Oct 5, 2010
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 23, 2009
- Review panel
- Immunology
- Regulation
- 21 CFR 866.6010
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files